Combining N-of-1 Trials to Estimate Population Clinical and Cost-effectiveness of Drugs Using Bayesian Hierarchical Modeling. The Case of Mexiletine for Patients With Non- Dystrophic Myotonia.
Phase of Trial: Phase II
Latest Information Update: 11 Dec 2018
Price : $35 *
At a glance
- Drugs Mexiletine (Primary)
- Indications Myotonia
- Focus Therapeutic Use
- Sponsors Radbound University Nijmegen
- 11 Dec 2018 Results published in the JAMA: the Journal of the American Medical Association
- 25 Jan 2016 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
- 12 Nov 2014 Planned End Date changed from 1 Mar 2015 to 1 Dec 2015 as reported by ClinicalTrials.gov.